Antiviral Drugs Advisory Committee

August 20, 2003 Meeting

Additional Meeting Participants

Acting Industry Representative (non-voting)

Kenneth R. Brown, M.D.

Independent Consultant on Vaccines, Antibiotics, and Tropical Medicine

8111 Winston Road

Philadelphia, Pennsylvania 19118

Consultants (voting)

Ralph B. D’Agostino, Ph.D.

Professor of Mathematics/Statistics and Public Health

Director Statistics and Consulting Unit

Director Framingham Study Statistics/Data Management

Editor Statistics in Medicine

Boston University

111 Cummington Street

Boston, Massachusetts 02215

Thomas R. Fleming, Ph.D.

Professor and Chair

Department of Biostatistics

University of Washington

Box 357232

Seattle, Washington 98195

Richard H. Haubrich, M.D.

Associate Adjunct Professor of Medicine

UCSD Antiviral Research Center

150 W. Washington Street, Suite 100

San Diego, California 92103

Alice M. Stek, M.D.

Assistant Professor of Clinical Obstetrics and Gynecology

Division of Women’s Health

University of Southern California, School of Medicine

Los Angeles County + University of Southern California Medical Center

Women’s & Children’s Hospital, Rm. 5K40

1240 North Mission Road

Los Angeles, California 90033

Guest Speakers (non-voting)

Andrew Nunn, M.Sc.

Head, Division Without Portfolio

Medical Research Council

Clinical Trials Unit

222 Euston Road

London NW1 2DA, United Kingdom

Salim S. Abdool Karim, M.D., Ph.D.

Director, Centre for the AIDS Programme of Research in South Africa

University of Natal

King George V Avenue

Durban 4041

South Africa

Lut Van Damme, M.D., M.Sc.

International Clinical Research Manager

CONRAD

1611 North Kent Street, Suite 806

Arlington, Virginia 22209

HHS Federal Guests (non-voting)

Jorge Flores, M.D.

Chief, Vaccine Clinical Research Branch

Vaccine and Prevention Research Program

Division of AIDS, National Institutes of Health

6700-B Rockledge Drive, MSC 7628

4^th Floor, Room 4154

Bethesda, Maryland 20892

Lynn Paxton, M.D., M.P.H.

Chief, Sexual Transmission and Injection Drug Use

Studies Section, DHAP-SE

Centers for Disease Control and Prevention

1600 Clifton Road, MS-E45

Atlanta, Georgia 30333

Patient Representative (voting)

Lori Heise

Director, Global Campaign for Microbicides

1800 K Street, NW, Suite 800

Washington, DC 20006

Open Public Hearing Speakers

Richard Bax, M.D.

Vice President and Chief Scientific Officer

Biosyn, Inc.

Polly Harrison, Ph.D.

Director

Alliance for Microbicide Development

Ian McGowan, M.D., Ph.D.

Associate Professor of Medicine

Co-Director, Center for HIV & Digestive Diseases

David Geffen School of Medicine at UCLA

Don Waldron, Ph.D.

Head of Clinical Research Unit

Center for Biomedical Research

Population Council, Rockefeller University

Tim Farley, Ph.D.

Coordinator

Controlling Sexually Transmitted and Reproductive Tract Infections

Department of Reproductive Health and Research

World Health Organization

Amy Allina

National Women’s Health Network

Rosalie Dominik, DrPH

Director of Biostatistics

Family Health International

Zena Stein, M.A., M.B., B.Ch.

Professor of Epidemiology and Psychiatry Emerita

Columbia University

Malcolm Potts, MB, BChir, PhD, FRCOG

Bixby Professor

School of Public Health

University of California, Berkeley

Laurie N. Sylla, MHSA, BSW written submission only

Director, Connecticut AIDS Education and Training Center

Yale University School of Nursing

Robert Munk, Ph.D. written submission only

New Mexico AIDS InfoNet

Anna Forbes written submission only

Global North Programs Coordinator

Global Campaign for Microbicides